AI
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
13F filer · CIK 0002032331Reported Aug 13, 2026
Net buyer this quarter
13F portfolio value$459MU.S. long equity reported on 13F
Positions11075 new · 30 closed
Net flow last quarter+$250MBuys minus sells
Top 10 positions weight47.3%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 13, 2026110 positions | |||||
| $32.9M | 7.17% | 0.01% | Not reported | Q1 2025 | |
| $31.3M | 6.82% | 0.01% | Not reported | Q1 2025 | |
| $27.9M | 6.07% | 0.14% | New | Q2 2026 | |
| $25.6M | 5.57% | 0.04% | Not reported | Q4 2024 | |
| $25.4M | 5.54% | 0.03% | New | Q2 2026 | |
| $25.1M | 5.47% | 0.00% | Not reported | Q4 2024 | |
| $24.5M | 5.34% | 0.00% | New | Q2 2026 | |
| $12.3M | 2.69% | 0.00% | +11.0% | Q4 2025 | |
| $7.52M | 1.64% | 0.00% | Not reported | Q4 2024 | |
| $4.66M | 1.02% | 0.00% | Not reported | Q1 2025 | |
| $4.57M | 0.99% | 0.00% | Not reported | Q4 2025 | |
| $4.07M | 0.89% | 0.01% | Not reported | Q4 2024 | |
| $3.85M | 0.84% | 0.01% | Not reported | Q1 2025 | |
| $3.77M | 0.82% | 0.00% | Not reported | Q4 2024 | |
| $3.39M | 0.74% | 0.03% | -15.7% | Q4 2025 | |
| $3.22M | 0.70% | 0.01% | +329.9% | Q4 2025 | |
| $3.18M | 0.69% | 0.00% | +46.8% | Q1 2025 | |
| $3.18M | 0.69% | 0.03% | New | Q2 2026 | |
| $3.15M | 0.69% | 0.03% | +392.0% | Q3 2025 | |
| $3.13M | 0.68% | 0.06% | New | Q2 2026 | |
| $3.11M | 0.68% | 0.01% | Not reported | Q4 2024 | |
| $3.06M | 0.67% | 0.00% | +476.5% | Q4 2025 | |
| $3.04M | 0.66% | 0.02% | New | Q2 2026 | |
| $3.01M | 0.66% | 0.04% | -7.1% | Q3 2025 | |
| $3M | 0.65% | 0.00% | Not reported | Q4 2025 | |
| $2.96M | 0.65% | 0.05% | New | Q2 2026 | |
| $2.9M | 0.63% | 0.01% | Not reported | Q4 2024 | |
| $2.78M | 0.61% | 0.02% | -23.5% | Q4 2025 | |
| $2.78M | 0.61% | 0.01% | +217.7% | Q4 2025 | |
| $2.56M | 0.56% | 0.00% | Not reported | Q4 2024 | |
| $2.49M | 0.54% | 0.02% | +489.3% | Q4 2024 | |
| $2.09M | 0.45% | 0.03% | +50.5% | Q4 2025 | |
| $2.06M | 0.45% | 0.00% | Not reported | Q4 2025 | |
| $1.97M | 0.43% | 0.07% | New | Q2 2026 | |
| $1.79M | 0.39% | 0.01% | New | Q2 2026 | |
| $1.68M | 0.37% | 0.00% | New | Q2 2026 | |
| $1.57M | 0.34% | 0.04% | New | Q2 2026 | |
| $1.55M | 0.34% | 0.01% | -44.5% | Q1 2026 | |
| $1.48M | 0.32% | 0.00% | +45.3% | Q1 2025 | |
| $1.46M | 0.32% | Not reported | New | Q2 2026 | |
| $1.4M | 0.30% | 0.00% | Not reported | Q1 2025 | |
| $1.3M | 0.28% | 0.02% | Not reported | Q3 2025 | |
| $1.27M | 0.28% | 0.01% | New | Q2 2026 | |
| $1.14M | 0.25% | 0.00% | -23.5% | Q3 2025 | |
| $1.04M | 0.23% | 0.00% | -13.2% | Q1 2026 | |
| $1M | 0.22% | 0.01% | +132.6% | Q4 2025 | |
| $978K | 0.21% | 0.01% | -68.4% | Q3 2025 | |
| $824K | 0.18% | 0.01% | -36.2% | Q4 2025 | |
| $764K | 0.17% | 0.00% | -5.3% | Q4 2024 | |
| $753K | 0.16% | 0.01% | +19.6% | Q4 2025 | |
| Q1 2026Reported May 14, 202665 positions | |||||
| $8.95M | 7.96% | 0.00% | +2123.4% | Q4 2025 | |
| $3.89M | 3.46% | 0.00% | Not reported | Q4 2024 | |
| $2.93M | 2.60% | 0.02% | +55.9% | Q3 2025 | |
| $2.84M | 2.52% | 0.02% | +512.9% | Q4 2025 | |
| $2.77M | 2.46% | 0.03% | +677.3% | Q4 2025 | |
| $2.75M | 2.45% | 0.03% | New | Q1 2026 | |
| $2.71M | 2.40% | 0.02% | +294.7% | Q4 2025 | |
| $2.7M | 2.40% | 0.05% | +329.8% | Q3 2025 | |
| $2M | 1.78% | 0.00% | +64.5% | Q4 2025 | |
| $1.93M | 1.72% | 0.00% | +62.7% | Q1 2025 | |
| $1.93M | 1.72% | 0.00% | -97.5% | Q4 2025 | |
| $1.74M | 1.54% | 0.00% | -17.2% | Q4 2024 | |
| $1.67M | 1.48% | 0.00% | -38.4% | Q4 2025 | |
| $1.52M | 1.35% | 0.00% | +1.4% | Q1 2025 | |
| $1.41M | 1.25% | 0.00% | Not reported | Q1 2025 | |
| $1.24M | 1.10% | 0.01% | +85.2% | Q4 2025 | |
| $1.15M | 1.02% | 0.00% | -39.3% | Q4 2025 | |
| $984K | 0.87% | 0.01% | New | Q1 2026 | |
| $957K | 0.85% | 0.02% | +96.9% | Q4 2025 | |
| $869K | 0.77% | 0.00% | New | Q1 2026 | |
| $863K | 0.77% | 0.00% | +64.8% | Q1 2025 | |
| $777K | 0.69% | 0.00% | -83.1% | Q4 2025 | |
| $775K | 0.69% | 0.00% | +149.1% | Q3 2025 | |
| $647K | 0.58% | 0.31% | -31.5% | Q3 2025 | |
| $640K | 0.57% | 0.02% | +34.9% | Q4 2025 | |
| $624K | 0.55% | 0.01% | +221.3% | Q3 2025 | |
| $612K | 0.54% | 0.00% | New | Q1 2026 | |
| $594K | 0.53% | 0.00% | Not reported | Q4 2024 | |
| $539K | 0.48% | 0.03% | -15.3% | Q4 2025 | |
| $531K | 0.47% | 0.01% | +87.5% | Q3 2025 | |
| $487K | 0.43% | 0.01% | +64.9% | Q4 2025 | |
| $430K | 0.38% | Not reported | -62.9% | Q4 2025 | |
| $430K | 0.38% | 0.00% | +97.8% | Q4 2025 | |
| $428K | 0.38% | 0.01% | New | Q1 2026 | |
| $422K | 0.37% | 0.00% | -43.5% | Q4 2024 | |
| $407K | 0.36% | 0.00% | -95.2% | Q4 2025 | |
| $402K | 0.36% | 0.01% | New | Q1 2026 | |
| $395K | 0.35% | 0.00% | -95.1% | Q4 2025 | |
| $373K | 0.33% | 0.00% | New | Q1 2026 | |
| $364K | 0.32% | 0.05% | New | Q1 2026 | |
| ATAPGEApogee Therapeutics, Inc. | $337K | 0.30% | 0.01% | -36.6% | Q4 2025 |
| $315K | 0.28% | 0.00% | New | Q1 2026 | |
| $313K | 0.28% | 0.00% | New | Q1 2026 | |
| $312K | 0.28% | 0.01% | +19.7% | Q4 2025 | |
| $310K | 0.28% | 0.01% | -55.3% | Q4 2025 | |
| $309K | 0.27% | 0.01% | New | Q1 2026 | |
| $273K | 0.24% | Not reported | Not reported | Q1 2025 | |
| $265K | 0.24% | Not reported | New | Q1 2026 | |
| $252K | 0.22% | 0.01% | New | Q1 2026 | |
| EEQHEquitable Holdings, Inc. | $252K | 0.22% | 0.00% | New | Q1 2026 |
| Q4 2025Reported Feb 11, 202684 positions | |||||
| $82.5M | 12.15% | 0.00% | +22456.1% | Q4 2024 | |
| $70.1M | 10.33% | 0.00% | New | Q4 2025 | |
| $65M | 9.57% | 0.01% | New | Q4 2025 | |
| $54.1M | 7.98% | 0.03% | Not reported | Q1 2025 | |
| $54M | 7.95% | 0.02% | Not reported | Q4 2024 | |
| $53.5M | 7.88% | 0.03% | New | Q4 2025 | |
| $49.6M | 7.31% | 0.01% | New | Q4 2025 | |
| $20.3M | 2.99% | 0.00% | Not reported | Q4 2024 | |
| $19.6M | 2.88% | 0.00% | New | Q4 2025 | |
| $19.5M | 2.87% | Not reported | +31.1% | Q4 2024 | |
| $19.3M | 2.85% | 0.00% | Not reported | Q4 2024 | |
| $18.9M | 2.79% | 0.04% | Not reported | Q4 2024 | |
| $9.88M | 1.46% | 0.00% | New | Q4 2025 | |
| $4.91M | 0.72% | 0.00% | Not reported | Q1 2025 | |
| $4.77M | 0.70% | 0.01% | New | Q4 2025 | |
| $4.23M | 0.62% | 0.02% | New | Q4 2025 | |
| $3.11M | 0.46% | Not reported | New | Q4 2025 | |
| $2.38M | 0.35% | 0.00% | New | Q4 2025 | |
| $2.37M | 0.35% | 0.01% | New | Q4 2025 | |
| $2.33M | 0.34% | 0.00% | Not reported | Q4 2024 | |
| $2.29M | 0.34% | Not reported | New | Q4 2025 | |
| $2.01M | 0.30% | 0.01% | New | Q4 2025 | |
| $1.98M | 0.29% | 0.02% | +357.9% | Q3 2025 | |
| $1.96M | 0.29% | Not reported | New | Q4 2025 | |
| $1.95M | 0.29% | 0.00% | +5859.0% | Q4 2024 | |
| $1.92M | 0.28% | 0.02% | New | Q4 2025 | |
| $1.84M | 0.27% | 0.00% | New | Q4 2025 | |
| $1.58M | 0.23% | 0.45% | Not reported | Q3 2025 | |
| $1.53M | 0.23% | 0.01% | -46.6% | Q3 2025 | |
| $1.53M | 0.22% | 0.00% | Not reported | Q1 2025 | |
| $1.4M | 0.21% | 0.00% | New | Q4 2025 | |
| $1.4M | 0.21% | 0.00% | New | Q4 2025 | |
| $1.33M | 0.20% | Not reported | New | Q4 2025 | |
| $1.23M | 0.18% | 0.00% | Not reported | Q4 2024 | |
| $1.2M | 0.18% | 0.00% | Not reported | Q4 2024 | |
| $1.19M | 0.18% | 0.00% | Not reported | Q4 2024 | |
| $1.19M | 0.17% | 0.00% | Not reported | Q1 2025 | |
| $1.14M | 0.17% | 0.06% | Not reported | Q2 2025 | |
| $1.08M | 0.16% | 0.13% | +8028.6% | Q3 2025 | |
| $1.08M | 0.16% | 0.00% | New | Q4 2025 | |
| $871K | 0.13% | 0.01% | Not reported | Q2 2025 | |
| $855K | 0.13% | 0.01% | Not reported | Q4 2024 | |
| $855K | 0.13% | 0.00% | New | Q4 2025 | |
| $854K | 0.13% | 0.00% | -14.0% | Q4 2024 | |
| $808K | 0.12% | 0.01% | Not reported | Q1 2025 | |
| $747K | 0.11% | 0.00% | -14.7% | Q4 2024 | |
| $702K | 0.10% | 0.01% | +180.7% | Q3 2025 | |
| $639K | 0.09% | 0.00% | New | Q4 2025 | |
| $628K | 0.09% | 0.04% | New | Q4 2025 | |
| $616K | 0.09% | 0.04% | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 202542 positions | |||||
| $15.4M | 15.40% | Not reported | Not reported | Q4 2024 | |
| $3.77M | 3.77% | 0.10% | New | Q3 2025 | |
| $3.4M | 3.40% | 0.01% | Not reported | Q4 2024 | |
| $2.73M | 2.73% | 0.02% | New | Q3 2025 | |
| $1.85M | 1.85% | Not reported | New | Q3 2025 | |
| $1.76M | 1.76% | 0.01% | New | Q3 2025 | |
| $1.69M | 1.69% | 0.43% | New | Q3 2025 | |
| $1.6M | 1.60% | 0.00% | +7.5% | Q4 2024 | |
| $1.54M | 1.53% | Not reported | Not reported | Q4 2024 | |
| $1.53M | 1.53% | Not reported | Not reported | Q1 2025 | |
| $1.5M | 1.50% | 0.01% | Not reported | Q4 2024 | |
| $1.42M | 1.41% | 0.03% | New | Q3 2025 | |
| $1.39M | 1.39% | 0.00% | -85.5% | Q4 2024 | |
| $764K | 0.76% | 0.01% | New | Q3 2025 | |
| $742K | 0.74% | 0.00% | Not reported | Q4 2024 | |
| $733K | 0.73% | 0.00% | Not reported | Q4 2024 | |
| $726K | 0.73% | 0.00% | Not reported | Q4 2024 | |
| $705K | 0.70% | 0.00% | New | Q3 2025 | |
| HHOLXHologic Inc | $576K | 0.58% | 0.00% | New | Q3 2025 |
| $540K | 0.54% | 0.00% | Not reported | Q4 2024 | |
| $473K | 0.47% | 0.01% | New | Q3 2025 | |
| $438K | 0.44% | 0.01% | New | Q3 2025 | |
| $431K | 0.43% | 0.01% | Not reported | Q4 2024 | |
| $426K | 0.43% | 0.01% | Not reported | Q4 2024 | |
| $366K | 0.37% | 0.00% | -92.8% | Q4 2024 | |
| $363K | 0.36% | 0.00% | New | Q3 2025 | |
| $358K | 0.36% | 0.00% | Not reported | Q4 2024 | |
| $357K | 0.36% | 0.00% | New | Q3 2025 | |
| $298K | 0.30% | 0.00% | New | Q3 2025 | |
| $257K | 0.26% | 0.04% | New | Q3 2025 | |
| $231K | 0.23% | 0.01% | New | Q3 2025 | |
| $205K | 0.20% | 0.00% | New | Q3 2025 | |
| $203K | 0.20% | 0.00% | Not reported | Q4 2024 | |
| $203K | 0.20% | 0.00% | New | Q3 2025 | |
| $202K | 0.20% | 0.00% | New | Q3 2025 | |
| ETESPREsperion Therapeutics, Inc. | $107K | 0.11% | 0.02% | New | Q3 2025 |
| $105K | 0.10% | 0.01% | New | Q3 2025 | |
| VBVTYXVentyx Biosciences, Inc. | $83.5K | 0.08% | 0.04% | New | Q3 2025 |
| $55.7K | 0.06% | 0.03% | New | Q3 2025 | |
| $39.9K | 0.04% | 0.00% | New | Q3 2025 | |
| $28.2K | 0.03% | 0.00% | Not reported | Q4 2024 | |
| $13.7K | 0.01% | 0.00% | New | Q3 2025 | |
Premium opens every quarter this fund has filed